Clinical Trial Update: Role of Pain Modulation in GERD Patients Who Failed Standard Dose Proton Pump Inhibitors (PPI) [Phase 4]

View source ↗

Summary

This Phase 4 trial update reports the completion of a study evaluating pain modulation strategies in patients with gastroesophageal reflux disease who failed st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Snippet

Sponsor: University of Arizona | Conditions: Gastroesophageal Reflux Disease | Phase 4 | Status: COMPLETED